Compounds > (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane
Page last updated: 2024-08-26

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Parkinson Disease, Secondary

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with Parkinson Disease, Secondary in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brownell, AL; McNaught, KS; Olanow, CW; Perl, DP1
Abbey, R; Alexander, M; Brasic, J; Dannals, RF; Kumar, A; Kuwabara, H; McCann, UD; Palermo, M; Ricaurte, GA; Wong, DF; Ye, W1
Brownell, AL; Brownell, GL; Burns, L; Elmaleh, D; Hantraye, P; Pakzaban, P; Petto, AJ; Shoup, T; Spealman, RD; Wüllner, U1
Isacson, O1
Brownell, AL; Brownell, GL; Elmaleh, DR; Fischman, AJ; Madras, BK; Meltzer, PC; Shoup, TM1
Dannals, RF; McCann, UD; Ricaurte, GA; Villemagne, V; Wong, DF; Yokoi, F1
Brashear, A; Farlow, MR; Hutchins, GD; Mulholland, GK; Siemers, ER; Zheng, QH1
Brownell, AL; Brownell, GL; Elmaleh, D; Hantraye, P; Isacson, O; Madras, BK; Spealman, RD; Wüllner, U1

Other Studies

8 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and Parkinson Disease, Secondary

ArticleYear
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.
    Annals of neurology, 2004, Volume: 56, Issue:1

    Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Carbon Radioisotopes; Cocaine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dopamine Uptake Inhibitors; Hazardous Substances; Humans; Inclusion Bodies; Male; Molecular Structure; Multienzyme Complexes; Oligopeptides; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed

2004
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
    Synapse (New York, N.Y.), 2008, Volume: 62, Issue:2

    Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Cocaine; Cognition; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography

2008
Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.
    Experimental neurology, 1994, Volume: 126, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Dopamine; Motor Activity; Nerve Endings; Parkinson Disease, Secondary; Putamen; Tomography, Emission-Computed

1994
Clinical and preclinical PET correlates of parkinsonism with 11C-WIN 35,428.
    Annals of neurology, 1994, Volume: 35, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbon Radioisotopes; Cocaine; Humans; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed

1994
Cocaine congeners as PET imaging probes for dopamine terminals.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Carbon Radioisotopes; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Female; Macaca fascicularis; Male; Nerve Endings; Parkinson Disease, Secondary; Tomography, Emission-Computed

1996
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Oct-15, Volume: 18, Issue:20

    Topics: Adult; Amphetamine-Related Disorders; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Propiophenones; Tomography, Emission-Computed

1998
PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Adult; Aged; Brain Mapping; Carbon Radioisotopes; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Uptake Inhibitors; Dystonia; Female; Homovanillic Acid; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Receptors, Dopamine; Receptors, Presynaptic; Tomography, Emission-Computed

1999
Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism.
    Neuroreport, 1992, Volume: 3, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Disease Models, Animal; Dopamine; Immunohistochemistry; Macaca fascicularis; Motor Activity; Nerve Fibers; Parkinson Disease, Secondary; Radioligand Assay; Tomography, Emission-Computed

1992